Imperial College London Limited

3 trials 1 recruiting Academic / non-commercial Merged from 2 name variants

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

1 Completed trials

8 Countries active

6 Unique IMPs

100% Results reported

Phase II

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

HIV infection 1

Top IMPs

10-1074-LS 1 SODIUM CHLORIDE 1 TEROPAVIMAB 1 TEZEPELUMAB 1

All trials

3 total

A RAndomised Placebo Controlled Trial - to Explore the Efficacy and Mechanism of Action of Tezepelumab in EGPA- RACE-MATE Not authorised

2024-514794-22-01 Phase II 1 country TEZEPELUMAB
RIO Trial Recruiting

2024-514564-13-00 Phase II 6 countries 10-1074-LS; SODIUM CHLORIDE; TEROPAVIMAB
A clinical trial to test a combination of lifestyle-based intervention with metformin in preventing dementia. Ended

2022-500438-27-01 Phase II 2 countries

Showing 1–3 of 3 trials

← All sponsors A–Z